An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial-Reference-Cited by-同舟云学术

An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial

Published:2021-06 Issue: Volume:Volume 16 Page:1607-1619
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Cahn Anthony,Hamblin J Nicole,Robertson Jon,Begg Malcolm^ORCID,Jarvis Emily^ORCID,Wilson Robert,Dear Gordon,Leemereise Claudia,Cui Yi,Mizuma Maki,Montembault Mickael,Van Holsbeke Cedric^ORCID,Vos Wim,De Backer Wilfried,De Backer Jan,Hessel Edith M^ORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference38 articles.

1. From the Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020. Available from: http://goldcopd.org/. Accessed May 6, 2021.

2. COPD exacerbations: defining their cause and prevention

3. Acute Exacerbations of Chronic Obstructive Pulmonary Disease

4. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study

5. Risk Indexes for Exacerbations and Hospitalizations Due to COPD

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rethinking bronchiectasis as an inflammatory disease;The Lancet Respiratory Medicine;2024-07

2. Efficacy of Nemiralisib in Chronic Obstructive Pulmonary Disease: A Systematic Review;Clinical Therapeutics;2024-04

3. The future drug treatment of COPD;COPD in the 21st Century;2024-03-01

4. Novel Anti-Inflammatory Approaches to COPD;International Journal of Chronic Obstructive Pulmonary Disease;2023-06

5. An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome;Pulmonary Pharmacology & Therapeutics;2023-04